Novi, Vinni Thekkudan
Gonzalez, Andrew
Brockgreitens, John
Abbas, Abdennour
Funding for this research was provided by:
USDA National Institute of Food and Agriculture (1006789, 1006789)
USDA Small Business Innovation Research (2020-33610-32483, 2020-33610-32483)
US Army Department of Defense Small Business Technology Transfer (W911QY-19-P-0180, W911QY-19-P-0180)
Centers for Disease Control and Prevention award (75D30121C10530, 75D30121C10530)
Article History
Received: 11 July 2022
Accepted: 13 October 2022
First Online: 15 October 2022
Competing interests
: The antimicrobial textile described in this paper is commercialized by Claros Technologies under the brand name ZioShield. Dr. Abdennour Abbas holds equity in, and is the founder and Chief Technology Officer of, Claros Technologies Inc., which has a license from the University of Minnesota to commercialize the technology described in this manuscript. Andrew Gonzalez holds equity in, and is the Lead Materials Engineer of, Claros Technologies. Dr. John Brockgreitens holds equity in, and is the Director of Research and Development of, Claros Technologies. The University of Minnesota also has equity and royalty interests in Claros. These interests have been reviewed and managed by the University of Minnesota in accordance with its Conflict-of-Interest policies. No other authors have any conflict of interest.